Apple is reportedly on the cusp of a significant technological leap, planning to integrate satellite-powered features into ...

Artiva remains on track to share initial clinical response data and conduct U.S. Food and Drug Administration (FDA) regulatory interactions to align on pivotal trial design for AlloNK in refractory ...

The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...

An update from Artiva Biotherapeutics, Inc. ( ($ARTV) ) is now available. On November 12, 2025, Artiva Biotherapeutics announced positive initial ...

As energy costs rise and sustainability targets tighten, CSPs are uniquely positioned to help data center operators optimize ...

Verizon's standard internet plan costs $60 per month, but you can cut that price by more than half if you do three simple ...

Google this week announced Private AI Compute, a new cloud-based system designed to deliver AI capabilities using its Gemini ...

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.

Apple today announced that iPhone users can now create a Digital ID in the Apple Wallet app based on information from their U ...

California Gold Nutrition's NMN supplement has been named the leading longevity formula by Expert Consumers, a trusted product review platform known for evaluating science-backed wellness solutions.

AlloNK plus anti-CD20 monoclonal antibody (mAb) as of October 1, 2025, data cutoff All patients received AlloNK as outpatients, and the majority were ...